EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decreased Expression of IL‐35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia

Xuan Cai iD, Ruo-Yun Gui, Jin Wu, Chen-Cong Wang, Xiao-Lu Zhu, Hai-Xia Fu, Xiao-Hui Zhang iD

Advanced Science · 2024-03 · 11 (12)

DOI: 10.1002/advs.202305798 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.01.2024. Verfasst von Xuan Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Beijing, 100044, China. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Chromones, Sulfonamides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science of Foundation of China, National Key Research and Development Program of China, Key Program of National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent findings have shown that the level of interleukin‐35 (IL‐35) is abnormal in several autoimmune diseases. Nonetheless, whether IL‐35 participates in the pathogenesis of immune thrombocytopenia (ITP) remains unclear. The current study investigates whether IL‐35 modulates megakaryopoiesis. The results show that IL‐35 receptors are progressively expressed on bone marrow megakaryocytes during the in vitro differentiation of CD34+ progenitors. IL‐35 increases the number of megakaryocyte colony‐forming units through the Akt pathway. The level of bone marrow IL‐35 is reduced in ITP patients, and the decreased level of IL‐35 may inhibit megakaryopoiesis. Then, the potential causes of decreased IL‐35 in ITP patients are explored. The primary type of cell that secretes IL‐35, known as IL‐35‐producing regulatory T cells (iTr35), is reduced in ITP patients. Bone marrow mesenchymal stem cells (MSCs) from ITP patients exhibit an impaired capability of inducing iTr35 due to enhanced apoptosis, which may contribute to the reduced level of bone marrow IL‐35 in ITP patients. Iguratimod promotes megakaryocyte development and differentiation by elevating the expression of IL‐35 receptors on megakaryocytes. Iguratimod improves response rates and reduces bleeding symptoms in corticosteroid‐resistant ITP patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicChromonesSulfonamidesHumansMegakaryocytesBone MarrowInterleukins

Stichwörter der Autor:innen

IL‐35iTr35iguratimodmegakaryopoiesismesenchymal stem cells

Substanzen

iguratimodInterleukinsChromonesSulfonamides

Autor:innen und Institutionen

  • Peking University People's Hospital, Beijing, 100044, China.
  • Peking University Institute of Hematology, Beijing, 100044, China.
  • National Clinical Research Center for Hematologic Disease, Beijing, 100044, China.
  • Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, 100044, China.

ORCID-Profile: Xuan Cai, Xiao-Hui Zhang

Förderung

  • National Natural Science of Foundation of China
  • National Key Research and Development Program of China
  • Key Program of National Natural Science Foundation of China
  • Capital Health Research and Development of Special

Zitieren

APA

Cai, X., Gui, R. Y., Wu, J., Wang, C. C., Zhu, X. L., Fu, H. X., & Zhang, X. H. (2024). Decreased Expression of IL‐35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia. Advanced Science, 11(12). https://doi.org/10.1002/advs.202305798

Vancouver

Cai X, Gui RY, Wu J, Wang CC, Zhu XL, Fu HX, et al. Decreased Expression of IL‐35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia. Advanced Science. 2024;11(12). doi:10.1002/advs.202305798

BibTeX
@article{Cai2024,
  author = {Cai, Xuan and Gui, Ruo-Yun and Wu, Jin and Wang, Chen-Cong and Zhu, Xiao-Lu and Fu, Hai-Xia and Zhang, Xiao-Hui},
  title = {Decreased Expression of IL‐35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {12},
  doi = {10.1002/advs.202305798}
}
Kostenlos starten →